Skip to content

Oral Prophylactic Measures on the Occurrence of Pre-eclampsia (OP-PE)

Effect of Oral Prophylactic Measures on the Occurrence of Pre-eclampsia (OP-PE) in High-risk Pregnant Women: A Cluster-randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04989075
Acronym
OP-PE
Enrollment
330
Registered
2021-08-04
Start date
2022-03-15
Completion date
2023-07-25
Last updated
2025-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Complications

Keywords

pre-eclampsia, pregnant, periodontal disease, interdental microbiota

Brief summary

Pre-eclampsia (PE) remains a major source of maternal and perinatal morbidity and mortality especially in low- and middle-income settings. PE, a pregnancy-specific hypertensive disorder, characterized by the development of placental endothelial dysfunction resulting in, among the most common diagnostic features, concomitant hypertension and proteinuria that may evolve into organs with fluctuating clinical specificities. Current studies indicate that periodontal disorders during pregnancy and particularly periodontal pathogens may be related to the risk of PE. Standard oral hygiene methods, based mainly on the joint use of toothbrushes and interdental brushes, reduce periodontal inflammatory risk, modulate of the dysbiotic oral microbiome. The purpose of the present study is to compare the PE outcomes in high-risk pregnant women receiving oral prophylactic measures to a control group. One specific question is addressed as follows according to the PICO principles: In high-risk pregnant women (Population), does oral prophylactic measures (Intervention) have a beneficial effect on PE parameters (Outcome) compared to pregnant women without any specific oral prophylactic measures (Control)?

Interventions

OTHEROral prophylactic intervention

The oral prophylactic intervention will consist of the provision of specific package including a soft-bristled manual toothbrush, toothpaste, and a kit of calibrated interdental brushes (IDBs)(Curaprox CPS; Curaden) of sizes corresponding to the diameter of their interdental spaces. The participants will be instructed to brush their teeeth twice-daily and to realise a daily interdental brushing until delivery. The instructions for the use of the toothbrush and IDBs comprised verbal instructions supported by practical demonstration. The first use of the material will be conducted under the supervision of a qualified public health professor.

Sponsors

Cheikh Anta Diop University, Senegal
CollaboratorOTHER
University of Ouagadougou, Burkina Faso
CollaboratorOTHER
Claude Bernard University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

This trial is designed as an two-arm parallel cluster randomized controlled trial with antenatal obstetric clinic as the unit of randomisation and an allocation ratio of 1:1

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* pregnant woman * women from sub-Saharan Africa * aged from 18 to 40 years old * nullipares at the time of the obstetrical consultation * up to 12 weeks pregnant * acceptance of the terms and conditions of the study * signature of the informed consent form,

Exclusion criteria

* fetal distress * congenital uterine and vaginal abnormalities * infectious or systemic diseases such as HIV, tuberculosis, candidiasis, cancers, hemopathies * premature termination of pregnancy for medical reasons * diagnosis of periodontitis defined as interproximal CAL ≥1 mm at ≥2 non-adjacent teeth, or buccal/oral CAL ≥3 mm with probing depth \>3 mm at ≥2 teeth, not attributable to non-periodontitis-related causes * history or treatment of PD * a course of dental or orthodontic treatment * absence of the 4 premolar-molar pairs * less than 20 natural teeth, excluding third molars * medication affecting the gum and/or oral mucosa * regularly using interdental brushes and/or dental floss and/or mouthwash * unable to answer questions or non-cooperative.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pre-eclampsia from baseline during the pregnancy9 months of pregnancyTo determine if pregnant women suffer from pre-eclampsia, several indices are measured (diastolic or systolic pressure and proteinuria or urinary protein/creatinine ratio). The combination of the results of pressure and proteinuria permits to classify of a woman as suffering from pre-eclampsia if: 1. the diastolic pressure is higher than 90 mm Hg on two 4 hours intervals, or \> 110 mm Hg once, or systolic pressure \> 140 mm Hg on two 4 hours intervals, or \> 160 mm Hg once, after 20 weeks of gestation and, 2. the proteinuria measured is of 2+ or more, or \> 300mg/24 hours, or \> 500mg/L or urinary protein/creatinine ratio \> 0.034g/mmol.

Secondary

MeasureTime frameDescription
Change of pocket probing depth of teeth during the pregnancy3, 4, 6 and 8 months of pregnancyQuantification of the pocket probing depth of the teeth with a periodontal probe
Change of clinical attachment level of teeth during the pregnancy3, 4, 6 and 8 months of pregnancyQuantification of the clinical attachment level of the teeth with a periodontal probe
Change of gingival index of teeth during the pregnancy3, 4, 6 and 8 months of pregnancyQuantification of the gingival index
Number of pathogenic bacteria in the interdental microbiota during the pregnancy3, 4, 6 and 8 months of pregnancyQuantitative PCR experiments will be performed and a quantitative analysis of the interdental microbiota will be made
Change of bleeding on probing during the pregnancy3, 4, 6 and 8 months of pregnancyQuantification of the bleeding on probing of the teeth with a periodontal probe

Countries

Senegal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026